Panic Disorder

• 

  Subject Areas on Research

  • A 69-year-old man with anger and angina. 
  • A Brief Interview to Detect Panic Attacks and Panic Disorder in Emergency Department Patients with Cardiopulmonary Complaints. 
  • ACP Journal Club: review: in primary care, screening with the GAD-7 detected anxiety disorder; the PHQ detected panic disorder. 
  • Adinazolam sustained-release treatment of panic disorder: a double-blind study. 
  • Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome. 
  • Adrenergic receptor function in panic disorder. II. Neutrophil beta 2 receptors: Gs protein coupling, effects of imipramine treatment and relationship to treatment outcome. 
  • Algorithm for the treatment of panic disorder with agoraphobia. 
  • Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder. 
  • Anxiety sensitivity as a predictor of the clinical course of panic disorder: a 1-year follow-up study. 
  • Avoidance behavior in panic disorder: the moderating influence of perceived control. 
  • Chest Pain: If It Is Not the Heart, What Is It? 
  • Children of currently depressed mothers: a STAR*D ancillary study. 
  • Cocaine use and the occurrence of panic attacks in the community: a case-crossover approach. 
  • Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. 
  • Consumers who call the Anxiety Disorders Association of America: characteristics and satisfaction. 
  • Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder. 
  • Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. 
  • Evidence Map of Yoga for Depression, Anxiety, and Posttraumatic Stress Disorder. 
  • Exceptionally high seizure threshold: ECT device limitations. 
  • Explained and unexplained medical symptoms in generalized anxiety and panic disorder: relationship to the somatoform disorders. 
  • Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder. 
  • Feared consequences of panic attacks in panic disorder: a qualitative and quantitative analysis. 
  • Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. 
  • Generalized anxiety disorder and panic disorder in the elderly: a review. 
  • How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. 
  • Impact of comorbid panic and posttraumatic stress disorder on outcomes of collaborative care for late-life depression in primary care. 
  • Keratomalacia in a Patient With Psychogenic Vitamin A Deficiency. 
  • Major depression, generalized anxiety disorder, and panic disorder in patients scheduled for knee arthroplasty. 
  • Morbidity of DSM-IV Axis I disorders in patients with noncardiac chest pain: Psychiatric morbidity linked with increased pain and health care utilization. 
  • Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. 
  • PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients. 
  • Panic attacks and suicide attempts in mid-adolescence. 
  • Panic disorder and social phobia: current treatments and new strategies. 
  • Panic disorder: making clinical sense of the latest research. 
  • Panic following trauma: the etiology of acute posttraumatic arousal. 
  • Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. 
  • Pivotal studies of clonazepam in panic disorder. 
  • Preoperative pain catastrophizing predicts pain outcome after knee arthroplasty. 
  • Prevalence of anxiety disorders in men and women with established coronary heart disease. 
  • Protocol for a multi-site randomized controlled trial of a stepped-care intervention for emergency department patients with panic-related anxiety. 
  • Psychiatric disorders in medical outpatients complaining of palpitations. 
  • Quality of life and cost factors in panic disorder. 
  • Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. 
  • Relapse following combined treatment discontinuation in a placebo-controlled trial for panic disorder. 
  • Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia. 
  • Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. 
  • Screening for panic-related anxiety in emergency department patients with cardiopulmonary complaints: A comparison of two self-report instruments. 
  • Simultaneous major depression and panic disorder: treatment with electroconvulsive therapy. 
  • The clinical course of palpitations in medical outpatients. 
  • The effects of clonazepam on quality of life and work productivity in panic disorder. 
  • The efficacy of new pharmacological treatments for panic disorder: evaluating the trials. 
  • The long-term treatment of panic disorder. 
  • The neurobiology of social phobia. 
  • Use of benzodiazepines in panic disorder. 
  • What do childhood anxiety disorders predict? 
  • What is generalized anxiety disorder? 
  • Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale. 
  • [A new quality of the therapy of anxiety and depression--escitalopram]. 
• 

  Keywords of People

  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine